Liver Cancer Therapeutics Market to Reach USD 7,382.1 Million by 2027; Rising Cases of Liver Cancer to Fuel Product Demand, states Fortune Business Insights™

Key Prominent Players Covered in the Liver Cancer Therapeutics Market Research Report Are Bayer HealthCare Pharmaceuticals Inc., Bristol-Myers & Squibb Company, Pfizer Inc., Exelixis, Inc., Merck Sharp & Dohme Corp., Eisai Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd and other key market players.

Pune, India, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The global liver cancer therapeutics market size is expected to reach USD 7,382.1 million by 2027, registering a CAGR of 20.2% during the forecast period. The emergence of effective drugs and therapies for the treatment of liver cancer will subsequently spur lucrative opportunities for the market, states Fortune Business Insights, in a report. The market size stood at USD 1,730.9 million in 2019.

The report on the liver cancer therapeutics market, specifically mentions minute and significant improvements in the global market in recent times. The report also offers a wide-ranging study fixated on emerging trends and new innovative products. The robust research methodology involving primary interviews and desk research is covered in the report while also providing a noteworthy overview of the R&D activities and latest developments to support emerging companies to strengthen their position and strategize to remain at the forefront.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/liver-cancer-therapeutics-market-104657

Rising Cases of Liver Cancer to Boost Market

The increasing incidence of liver cancer is expected to expedite the growth of the market during the forecast period. Alcohol & tobacco consumption, smoking, and environmental factors in developed nations are some of the reasons for the prevalence of cancer. The increasing urbanization is expected to bolster the healthy growth of the market in the forthcoming years. According to the World Cancer Research Fund, in 2018, there were around 840 000 new cases of liver cancer. Moreover, the growing demand for effective drugs is predicted further to boost the market's development in the foreseeable future. However, oncology drugs' adverse side effects will consequently restrict their adoption, which will retard the growth of the market.

Favorable Guidelines and Recommendations for Cancer Drugs to Aid Market Amid COVID

The pharmaceutical companies are adopting strategies to maintain the balance between supply and demand. Health organizations have issued necessary guidelines and recommendations for managing hepatocellular carcinoma patients in the time coronavirus. For instance, the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), National Institute of Health and Care Excellence (NICE) have proposed guidelines. Furthermore, several research studies have confirmed that patients with HCC are at higher risk of contracting the infection. Therefore, these patients were considered in the emergency category during the pandemic. Besides, the increased sales of cancer products will foster healthy growth of the market amid COVID-19.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/liver-cancer-therapeutics-market-104657

Presence of Prominent Companies to Incite Growth in North America

The market in North America is expected to expand radically during the forecast period owing to the rising incidence of liver cancer in the US. The presence of major companies, coupled with the launch of novel products will influence growth in the region. Europe is expected to expand radically during the forecast period due to the R&D investments to develop effective drugs.

The higher sales of targeted drug therapy products is expected to boost the growth of the market in Europe. Asia Pacific is expected to rise excellently during the forecast period owing to the growing number of clinical studies pertaining to liver cancer. The increasing geriatric population is likely to contribute impetus in the region. Latin America, and Middle East & Africa are likely to experience a slower growth rate owing to lower adoption of high-cost liver cancer drugs. Similarly, the lack of product approvals in the majority of the under-developed countries can further dampen the growth of the market in those regions.

Quick Buy - Liver Cancer Therapeutics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104657

Key Development:

November 2020: Exelixis, a genomics-based drug discovery company, located in Alameda, California, announced the approval of CABOMETYX in Japan for the treatment of unresectable hepatocellular carcinoma.

The Report Lists the Key Companies in the Liver Cancer Therapeutics Market:

• Bayer HealthCare Pharmaceuticals Inc. (Leverkusen, Germany)

• Bristol-Myers & Squibb Company (New York, U.S)

• Pfizer Inc. (New York, U.S)

• Exelixis, Inc. (California, U.S)

• Merck Sharp & Dohme Corp. (New jersey, U.S)

• Eisai Inc. (Tokyo, Japan)

• Eli Lilly and Company (Indiana, U.S)

• F. Hoffmann-La Roche Ltd (Basel, Switzerland)

• Other Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/liver-cancer-therapeutics-market-104657

Table of Contents:

• Introduction

  • Market Scope

  • Market Segmentation

  • Market Methodology

  • Definitions and Assumptions

• Executive Summary

• Market Dynamics

  • Market Drivers

  • Market Restraints

  • Market Opportunities

• Key Insights

  • Prevalence of Liver Cancer –Key Regions/Country

  • New Product Launch

  • Pipeline Analysis

  • Impact of COVID-19 on the Liver Cancer Treatment Market

  • Key Industry Developments - Mergers, Acquisitions, and Partnerships

• Global Liver Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027

  • Key Findings / Summary

  • Market Analysis, Insights and Forecast – By Therapy Type

    • Targeted Drug Therapy

    • Immunotherapy

    • Chemotherapy

  • Market Analysis, Insights and Forecast – By Distribution Channel

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

  • Market Analysis, Insights and Forecast – By Geography

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

TOC Continued….!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/liver-cancer-therapeutics-market-104657

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

• Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies

• Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.

• Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility

• Number of procedures and average price of procedures

• Replacement rate and pricing of capital equipment

• Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities

• Market & technological trends, new product developments, product pipeline.

Have a Look at Related Reports:

Dental Prosthetics Market Share & Industry Analysis, By Type (Crowns, Bridges, Abutments, Dentures, and Others), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026

Transcatheter Heart Valve Replacement (THVR) Market Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement (TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026

Compression Therapy Market Share and Industry Analysis, By Product (Compression Garments {Compression Bandages, Compression Stockings, and Others}, Compression Pumps, and Others), By Application (Venous Leg Ulcer, Deep Vein Thrombosis (DVT), Lymphedema, and Others), By End User (Hospitals & Clinics, Nursing Care Centers, Home Care, and Others), and Regional Forecast, 2019-2026

Impact Of Covid-19 On The Pharmaceuticals Market Share Impact Of Covid-19 On The Pharmaceuticals Market

Multiple Myeloma Market Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/global-liver-cancer-therapeutics-market-10450